HemaCore

Moscow, Russia Founded: 2010 • Age: 16 yrs
Instruments and assays for blood disorders are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About HemaCore

HemaCore is a company based in Moscow (Russia) founded in 2010. HemaCore operates in a competitive market with competitors including Hemex Health, BioMedomics, ShanMukha Innovations, Halcyon Biomedical and Silver Lake Research Corporation, among others.

  • Headquarter Moscow, Russia
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of HemaCore

Premium access

Detailed funding history for HemaCore

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by HemaCore

Investments
Premium access

Investment portfolio details for HemaCore

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - HemaCore

Premium access

Detailed financials for HemaCore

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Hemacore Comparisons

HemaCore Primary company
Description
Instruments and assays for blood disorders are provided.
Location
Moscow, Russia
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for HemaCore

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of HemaCore

HemaCore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemex Health, BioMedomics, ShanMukha Innovations, Halcyon Biomedical and Silver Lake Research Corporation, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Platform providing care devices for the detection of tropical diseases
Locked Locked Locked
Point-of-care diagnostic systems for blood-based disorders are developed.
Locked Locked Locked
Affordable point-of-care diagnostic solutions are developed for healthcare applications.
Locked Locked Locked
Diagnostic solutions for hematological disorders
Locked Locked Locked
Custom antibodies and diagnostics are developed for various applications.
Premium access

Detailed competitors of HemaCore

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Hemacore

Premium access

Complete news archive for HemaCore

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HemaCore

HemaCore was founded in 2010.

HemaCore is headquartered in Moscow, Russia.

Igor Pivovarov is the current CEO of HemaCore.

HemaCore was founded in 2010 in Moscow, Russia, as a provider of medical instruments and assays focused on blood disorders. The companys operations center on the Thrombodynamics analyzer, which employs microfluidics for hemostasis testing, along with related software and clotting assays. Sensitivity to pro- and anticoagulant shifts in hemostatic balance is achieved through real-time clot propagation visualization and observation of spontaneous clot formation.

HemaCore's top competitors include Hemex Health, Silver Lake Research Corporation and BioMedomics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available